Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Penson

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|May 17, 2020
Spotlight Commentary: What's new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomesPeter E Penson
Autonomic & Autacoid Pharmacology|June 23, 2016
Autonomic & Autacoid Pharmacology: past, present and futurePeter E Penson
Medical Hypotheses|December 20, 2008
Incense - A problematic method of drug-deliveryPeter E Penson
Atherosclerosis|January 23, 2021
Lipid-lowering therapies: Better togetherMaciej Banach, Peter E Penson
European Journal of Preventive Cardiology|February 14, 2022
Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly conditionMaciej Banach, Peter E Penson
Nutrients|September 28, 2021
Nutraceuticals for the Control of Dyslipidaemias in Clinical PracticePeter E Penson, Maciej Banach
JAMA Network Open|November 20, 2020
Statins and LDL-C in Secondary Prevention-So Much Progress, So Far to GoMaciej Banach, Peter E Penson
European Heart Journal|January 2, 2020
Statins and Lp(a): do not make perfect the enemy of excellentMaciej Banach, Peter E Penson
European Heart Journal|June 21, 2021
Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendationsPeter E Penson, Maciej Banach
Archives of Medical Science : AMS|March 22, 2021
Drucebo effect - the challenge we should all definitely face!Maciej Banach, Peter E Penson
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|May 17, 2020
Spotlight Commentary: What's new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomesPeter E Penson
Autonomic & Autacoid Pharmacology|June 23, 2016
Autonomic & Autacoid Pharmacology: past, present and futurePeter E Penson
Medical Hypotheses|December 20, 2008
Incense - A problematic method of drug-deliveryPeter E Penson
Atherosclerosis|January 23, 2021
Lipid-lowering therapies: Better togetherMaciej Banach, Peter E Penson
European Journal of Preventive Cardiology|February 14, 2022
Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly conditionMaciej Banach, Peter E Penson
Nutrients|September 28, 2021
Nutraceuticals for the Control of Dyslipidaemias in Clinical PracticePeter E Penson, Maciej Banach
JAMA Network Open|November 20, 2020
Statins and LDL-C in Secondary Prevention-So Much Progress, So Far to GoMaciej Banach, Peter E Penson
European Heart Journal|January 2, 2020
Statins and Lp(a): do not make perfect the enemy of excellentMaciej Banach, Peter E Penson
European Heart Journal|June 21, 2021
Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendationsPeter E Penson, Maciej Banach
Archives of Medical Science : AMS|March 22, 2021
Drucebo effect - the challenge we should all definitely face!Maciej Banach, Peter E Penson
Pageof 10